Skip to main content
. Author manuscript; available in PMC: 2023 Aug 3.
Published in final edited form as: ACS Appl Mater Interfaces. 2022 Jul 22;14(30):34354–34364. doi: 10.1021/acsami.2c06190

Figure 2.

Figure 2.

In vitro biocompatibility assays. (A) Viability of kidney (Renca) and liver (HepG2) cells in gray and blue, respectively, (B) ROS generation of kidney cells and liver cells in gray and blue, respectively, and (C) immunofluorescence staining of γH2AX in kidney and liver cells in gray and blue, respectively, after incubation with GSH-coated Ag2Te NPs at different Ag concentrations. In (C), + denotes positive controls (cells irradiated with a dose of 6 Gy 30 min prior to staining). Data are presented as mean ± SD. Statistical significances are compared to the control. *p < 0.05. ****p < 0.0001. n = 3 per condition and cell line.